Human ACE2 Polymorphisms from Different Human Populations Modulate SARS-CoV-2 Infection

Angiotensin-converting enzyme 2 (ACE2): Two decades of revelations and re-evaluation

(2022) Anthony J. Turner et al.   PEPTIDES

Population-Specific ACE2 Single-Nucleotide Polymorphisms Have Limited Impact on SARS-CoV-2 Infectivity In Vitro

(2021) Mei Hashizume et al.   Viruses-Basel

SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity

(2021) Seiya Ozono et al.   Nature Communications

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

(2021) Ahmad Reza Mehdipour et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Author Correction: Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

(2021) Xiuyuan Ou et al.   Nature Communications

Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2

(2021) Kushal Suryamohan et al.   Communications Biology

Variants in ACE2; potential influences on virus infection and COVID-19 severity

(2021) Behnaz Bakhshandeh et al.   INFECTION GENETICS AND EVOLUTION

The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target

(2021) Lobna Al-Zaidan et al.   TUMOR BIOLOGY

Susceptibilities of Human ACE2 Genetic Variants in Coronavirus Infection

(2021) Wenlin Ren et al.   JOURNAL OF VIROLOGY

Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS

(2020) Yushun Wan et al.   JOURNAL OF VIROLOGY

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

(2020) Roujian Lu et al.   LANCET

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Clinical Characteristics of Coronavirus Disease 2019 in China

(2020) Wei-jie Guan et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2020) Na Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

COVID-19: towards understanding of pathogenesis

(2020) Wei Cao et al.   CELL RESEARCH

Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?

(2020) Daniel Batlle et al.   CLINICAL SCIENCE

Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein

(2020) Mushtaq Hussain et al.   JOURNAL OF MEDICAL VIROLOGY

New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis

(2020) Yuan Hou et al.   BMC Medicine

Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses

(2020) Fabian Schmidt et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection

(2020) Jingfang Wang et al.   JOURNAL OF GENERAL VIROLOGY

ACE2, TMPRSS2 , and Furin variants and SARS‐CoV‐2 infection in Madrid, Spain

(2020) Laura Torre‐Fuentes et al.   JOURNAL OF MEDICAL VIROLOGY

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

(2020) Quan-Xin Long et al.   NATURE MEDICINE

Analysis of ACE2 Genetic Variability among Populations Highlights a Possible Link with COVID-19-Related Neurological Complications

(2020) Claudia Strafella et al.   Genes

Genetic variability of human angiotensin‐converting enzyme 2 (hACE2) among various ethnic populations

(2020) Quan Li et al.   Molecular Genetics & Genomic Medicine

Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein

(2020) Matteo Calcagnile et al.   BIOCHIMIE

Addendum: A pneumonia outbreak associated with a new coronavirus of probable bat origin

(2020) Peng Zhou et al.   NATURE